Literature DB >> 34188192

MYC protein interactors in gene transcription and cancer.

Diana Resetca1,2, Cornelia Redel1,2, Corey Lourenco1, Peter Lin1,2, Alannah S MacDonald1,2, Roberto Ciaccio3, Tristan M G Kenney1,2, Yong Wei1,4, David W Andrews2,4, Maria Sunnerhagen5, Cheryl H Arrowsmith1,2,6, Brian Raught1,2, Linda Z Penn7,8.   

Abstract

The transcription factor and oncoprotein MYC is a potent driver of many human cancers and can regulate numerous biological activities that contribute to tumorigenesis. How a single transcription factor can regulate such a diverse set of biological programmes is central to the understanding of MYC function in cancer. In this Perspective, we highlight how multiple proteins that interact with MYC enable MYC to regulate several central control points of gene transcription. These include promoter binding, epigenetic modifications, initiation, elongation and post-transcriptional processes. Evidence shows that a combination of multiple protein interactions enables MYC to function as a potent oncoprotein, working together in a 'coalition model', as presented here. Moreover, as MYC depends on its protein interactome for function, we discuss recent research that emphasizes an unprecedented opportunity to target protein interactors to directly impede MYC oncogenesis.

Entities:  

Year:  2021        PMID: 34188192     DOI: 10.1038/s41568-021-00367-9

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  152 in total

Review 1.  Analysis of genomic targets reveals complex functions of MYC.

Authors:  Jagruti H Patel; Andrey P Loboda; Michael K Showe; Louise C Showe; Steven B McMahon
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 2.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

Review 3.  Target gene-independent functions of MYC oncoproteins.

Authors:  Apoorva Baluapuri; Elmar Wolf; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-18       Impact factor: 94.444

4.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

5.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 6.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

Review 7.  Taming of the beast: shaping Myc-dependent amplification.

Authors:  Elmar Wolf; Charles Y Lin; Martin Eilers; David L Levens
Journal:  Trends Cell Biol       Date:  2014-12-01       Impact factor: 20.808

Review 8.  Drugging the 'undruggable' cancer targets.

Authors:  Chi V Dang; E Premkumar Reddy; Kevan M Shokat; Laura Soucek
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

Review 9.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 10.  Emerging roles of Myc in stem cell biology and novel tumor therapies.

Authors:  Go J Yoshida
Journal:  J Exp Clin Cancer Res       Date:  2018-07-27
View more
  29 in total

Review 1.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

2.  Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions.

Authors:  Yinghuan Dai; Ping Liu; Wenlong He; Lizhen Yang; Yang Ni; Xuejiao Ma; Furong Du; Chao Song; Yang Liu; Yi Sun
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

3.  Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression.

Authors:  Hsin-Yi Chen; Shu-Jou Chan; Xinxin Liu; An-Chi Wei; Ru-In Jian; Kuan-Wei Huang; Yaw-Dong Lang; Jou-Ho Shih; Chun-Chieh Liao; Chiu-Lin Luan; Yu-Tung Kao; Shang-Yin Chiang; Pei-Wen Hsiao; Yuh-Shan Jou; Yunching Chen; Ruey-Hwa Chen
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

4.  Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.

Authors:  Ziyue Li; Jierong Chen; Dandan Zhu; Xiaoxiao Wang; Jace Chen; Yu Zhang; Qizhou Lian; Bing Gu
Journal:  BMC Genom Data       Date:  2022-07-06

Review 5.  MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.

Authors:  Brian C Grieb; Christine M Eischen
Journal:  Biology (Basel)       Date:  2022-06-08

6.  Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.

Authors:  Xue Han; Chune Ren; Chao Lu; Pengyun Qiao; Tingting Yang; Zhenhai Yu
Journal:  Cell Death Differ       Date:  2022-03-16       Impact factor: 12.067

7.  EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesis.

Authors:  Jun Wang; Xufen Yu; Weida Gong; Xijuan Liu; Kwang-Su Park; Anqi Ma; Yi-Hsuan Tsai; Yudao Shen; Takashi Onikubo; Wen-Chieh Pi; David F Allison; Jing Liu; Wei-Yi Chen; Ling Cai; Robert G Roeder; Jian Jin; Gang Greg Wang
Journal:  Nat Cell Biol       Date:  2022-02-24       Impact factor: 28.213

8.  IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas.

Authors:  Ricardo Gargini; Berta Segura-Collar; María Garranzo-Asensio; Rafael Hortigüela; Patricia Iglesias-Hernández; Daniel Lobato-Alonso; Miguel Moreno-Raja; Santiago Esteban-Martin; Juan M Sepúlveda-Sánchez; Laura Nevola; Pilar Sánchez-Gómez
Journal:  Neurotherapeutics       Date:  2022-01-31       Impact factor: 6.088

9.  A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®.

Authors:  Lin Ming Lee; Eleni G Christodoulou; Pavithra Shyamsunder; Bei Jun Chen; Kian Leong Lee; Tsz Kan Fung; Chi Wai Eric So; Gee Chuan Wong; Enrico Petretto; Owen J L Rackham; S Tiong Ong
Journal:  Oncogene       Date:  2022-10-21       Impact factor: 8.756

10.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.